Dual inhibition of renin-angiotensin-aldosterone system and endothelin-1 in treatment of chronic kidney disease (Q26752292)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

The glomerulopathy of sickle cell disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Renal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and management

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Collecting duct-specific knockout of endothelin-1 alters vasopressin regulation of urine osmolality

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Endothelin-A receptor antagonist inhibits angiotensin II and noradrenaline in man

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Endothelin mediates some of the renal actions of acutely administered angiotensin II

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Endothelin-1/endothelin-B receptor-mediated increases in NHE3 activity in chronic metabolic acidosis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Emerging drugs for preeclampsia--the endothelium as a target

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Endothelin and the podocyte

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Endothelin and endothelin antagonists in chronic kidney disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

β-arrestin-1 drives endothelin-1-mediated podocyte activation and sustains renal injury

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

The renin-angiotensin-aldosterone system in podocytes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Chronic endothelin-1 infusion elevates glomerular sieving coefficient and proximal tubular albumin reuptake in the rat

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Endothelin in renal injury due to sickle cell disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Endothelin and collecting duct sodium and water transport

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Distinct actions of endothelin A-selective versus combined endothelin A/B receptor antagonists in early diabetic kidney disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Regulation of blood pressure and salt homeostasis by endothelin

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Endothelin-1 inhibits the epithelial Na+ channel through betaPix/14-3-3/Nedd4-2.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Avosentan for overt diabetic nephropathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

The incidence and implications of aldosterone breakthrough

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

A direct effect of aldosterone on endothelin-1 gene expression in vivo.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Regression of renal vascular fibrosis by endothelin receptor antagonism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Role of aldosterone in the remnant kidney model in the rat.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Endothelin stimulates phospholipase C, Na+/H+ exchange, c-fos expression, and mitogenesis in rat mesangial cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Endothelin inhibits vasopressin-stimulated water permeability in rat terminal inner medullary collecting duct

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Endothelin-1 inhibits thick ascending limb transport via Akt-stimulated nitric oxide production

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Collecting duct-derived endothelin regulates arterial pressure and Na excretion via nitric oxide

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

SRC family kinases mediate epithelial Na+ channel inhibition by endothelin

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Interaction of angiotensin II and TGF-beta 1 in the rat remnant kidney

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Effect of an endothelin antagonist on hemodynamic responses to angiotensin II.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

The endothelium-derived vasoconstrictor peptide endothelin inhibits renin release in vitro

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Effects of prolonged infusion with endothelin-1 on the function and morphology of rat adrenal cortex.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

The endothelin receptor antagonist, BQ-123, inhibits angiotensin II-induced contractions in rabbit aorta

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Endothelin-1 stimulates mitotic activity in the zona glomerulosa of the rat adrenal cortex

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats.

31 May 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00425.2015

Endothelin-a receptor blockade improves renal microvascular architecture and function in experimental hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00425.2015

Endothelin receptor antagonism and renin inhibition as treatment options for scleroderma kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00425.2015

Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00425.2015

Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00425.2015

Novel dual action AT1 and ETA receptor antagonists reduce blood pressure in experimental hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00425.2015

An autocrine role for endothelin-1 in the regulation of proximal tubule NHE3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00425.2015

Discovery of N-isoxazolyl biphenylsulfonamides as potent dual angiotensin II and endothelin A receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00425.2015

Effect on blood pressure of combined inhibition of endothelin-converting enzyme and neutral endopeptidase with daglutril in patients with type 2 diabetes who have albuminuria: a randomised, crossover, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00425.2015

Endothelin receptor blockade lowers plasma aldosterone levels via different mechanisms in primary aldosteronism and high-to-normal renin hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00425.2015

Endothelin-1 increases collagen accumulation in renal mesangial cells by stimulating a chemokine and cytokine autocrine signaling loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00425.2015

SGK1-dependent cardiac CTGF formation and fibrosis following DOCA treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00425.2015

The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00425.2015

A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00425.2015

Distinct cardiac and renal effects of ETA receptor antagonist and ACE inhibitor in experimental type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00425.2015

Endothelin inhibits renin release from isolated rat glomeruli

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00425.2015

Protein overload activates proximal tubular cells to release vasoactive and inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00425.2015

Chronic endothelin receptor blockade reduces end-organ damage independently of blood pressure effects in salt-loaded heterozygous Ren-2 transgenic rats

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4896079

Locally activated renin-angiotensin system associated with TGF-beta1 as a major factor for renal injury induced by chronic inhibition of nitric oxide synthase in rats

28 November 2018

1 reference

12 December 2020

Effects of irbesartan and bosentan on the blood pressure and adrenal zona glomerulosa function in heterozygous transgenic TGR[mREN2]27 rats

1 reference

12 December 2020

Blockade of the renin-angiotensin and endothelin systems on progressive renal injury

1 reference

12 December 2020

Blood pressure-independent additive effects of pharmacologic blockade of the renin-angiotensin and endothelin systems on progression in a low-renin model of renal damage

1 reference

12 December 2020

Comparative sensitivities of isolated rat renal arterioles to endothelin

1 reference

12 December 2020

Spironolactone ameliorates renal injury and connective tissue growth factor expression in type II diabetic rats

1 reference

12 December 2020

Involvements of Rho-kinase and TGF-beta pathways in aldosterone-induced renal injury

1 reference

12 December 2020

Endothelin-1 induces NF-kappaB via two independent pathways in human renal tubular epithelial cells

1 reference

12 December 2020

Effect of endothelin on angiotensin converting enzyme activity in cultured pulmonary artery endothelial cells

1 reference

12 December 2020

Endothelin synthesis by rabbit renal tubule cells

1 reference

12 December 2020

Cellular mechanism of endothelin-1 release by angiotensin and vasopressin

1 reference

12 December 2020

Effects of endothelin receptor antagonism relate to the degree of renin-angiotensin system blockade in chronic proteinuric kidney disease

1 reference

12 December 2020

Selective endothelin-A receptor antagonism reduces proteinuria, blood pressure, and arterial stiffness in chronic proteinuric kidney disease

1 reference

12 December 2020

Endothelin stimulates angiotensin I to angiotensin II conversion in cultured pulmonary artery endothelial cells

1 reference

12 December 2020

Addition of ETA receptor blockade increases renoprotection provided by renin–angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats

1 reference

12 December 2020

Scleroderma renal crisis

1 reference

12 December 2020

Secretory mechanism of immunoreactive endothelin in cultured bovine endothelial cells

1 reference

12 December 2020

Changes in plasma renin activity and aldosterone concentration in response to endothelin injection in dogs

1 reference

12 December 2020

Rationale and protocol of the Study of Diabetic Nephropathy with Atrasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy.

1 reference

12 December 2020

Heterogeneity in vascular smooth muscle responsiveness to angiotensin II. Role of endothelin

1 reference

12 December 2020

Effect of endothelin-1 on glomerular hydraulic pressure and renin release in dogs

1 reference

12 December 2020